Abstract
Objective
To study the correlation between pharmaceutical care and prescribing routines of general practitioners (GPs).
Methods
Cross-sectional study; 201 pharmacies, 408 general practices, The Netherlands, 2000/2001. The variation in prescribing behaviour was characterised using 20 validated prescribing indicators based on general practice guidelines. The general construct ‘adherence to guidelines’ served as the dependent variable and was formed by summing the scores of the prescribing indicators. Four possible determinants of the variation were determined on the basis of survey questions: the construct ‘the pharmacist’s attitude towards pharmaceutical care’, and three partial constructs derived from the pharmacist’s care-providing function: the care for the individual patient, the cooperation with general practitioners and the registration of the care provided. A multiple linear regression analysis was then performed.
Main outcome measure
The weighted score for the prescribing indicators.
Results
The weighted average score for the prescribing indicators was 65% (SD 3.7). The response rate to the survey was 71%. The pharmacist’s attitude to pharmaceutical care, as well as the degree to which the pharmacist provided care for the individual patient, the degree to which he cooperated with the general practitioner and the degree to which he registered the care provided were not correlated with the ‘adherence to guidelines’ by the general practitioner with whom the pharmacist frequently cooperated.
Conclusion
Variations between general practitioners in the quality of prescribing, as measured by their adherence to guidelines, were not correlated with pharmaceutical care by the pharmacist with whom they cooperated on a day-to-day basis.
Similar content being viewed by others
References
Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care 2003;12(1):29–34.
Mantyselka P, Ahonen R, Kumpusalo E, Takala J. Variability in prescribing for musculoskeletal pain in Finnish primary health care. Pharm World Sci 2001;(6):232–6.
Jones MI, Greenfield SM, Jowett S, Bradley CP, Seal R. Proton pump inhibitors: a study of GPs’ prescribing. Fam Pract 2001;18(3):333–8.
Bjerrum L, Bergman U . Wide variation in the number of different drugs prescribed by general practitioners. A prescription database study. Scand J Prim Health Care 2000;18(2):94–8.
Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 1999;49(440):195–8.
Guillemot D, Carbon C, Vauzelle-Kervroedan F, Balkau B, Maison P, Bouvenot G, Eschwege E. Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998;51(1):61–8.
McBride JE, Pater JL, Dorland JL, Lam YM. Extent and variation of omeprazole prescribing in an elderly population of Ontario. Ann Pharmacother 1997;31(4):411–6.
Muijrers PEM, Janknegt R, Sijbrandij J, Grol RP, Knottnerus JA Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners. Eur J Clin Pharmacol 2004;60(10):739–46.
Lawrence M, Olesen F. Indicators of quality in healthcare. Eur J Gen Pract 1997;3:103–8.
Van Mil JWF. Pharmaceutical care, the future of pharmacy. Theory, research and practice. (Dissertation). University of Groningen. The Netherlands; ISBN: 90-9013367-4, 1997.
Van der Heide H, Tinke JL. Facts and figures, cost development of pharmaceutical aid. The Hague, The Netherlands: Foundation for Pharmaceutical Statistics; 1999.
Van Mil JW, Dudok van Heel MC, Boersma M, Tromp TF. Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Health Syst Pharm 2001;58(15):1428–31.
De Gier JJ. The Electronic Pharmaceutical Dossier: an effective aid to documenting pharmaceutical care data. Pharm World Sci 1996;18(6):241–3.
Kirking DM, Thomas JW, Ascione FJ, Boyd EL. Detecting and preventing adverse drug interactions: the potential contribution of computers in pharmacies. Soc Sci Med 1986;22(1):1–8.
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3):533–43.
Hakansson A, Andersson H, Cars H, Melander A. Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care. Eur J Clin Pharmacol 2001;57(1):65–70.
Kocken GA. Medication discussion groups in the Netherlands: five years of experience. Med Educ 1999;33(5):390–3.
Bradley CP, Taylor RJ, Blenkinsopp A. Primary care–opportunities and threats. Developing prescribing in primary care. BMJ 1997;314(7082):744–7.
Matheson C, Bond CM, Mollison J. Attitudinal factors associated with community pharmacists’ involvement in services for drug misusers. Addiction 1999;94(9):1349–59.
Farris KB, Schopflocher DP. Between intention and behavior: an application of community pharmacists’ assessment of pharmaceutical care. Soc Sci Med 1999;49(1):55–66.
Odedina FT, Hepler CD, Segal R, Miller D. The Pharmacists’ Implementation of Pharmaceutical Care (PIPC) model. Pharm Res 1997;14(2):135–44.
Carroll NV. Do community pharmacists influence prescribing? J Am Pharm Assoc (Wash DC) 2003;43(5):612–21.
Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review). In: The Cochrane Library, vol. 4. Oxford; 2001.
Guidelines for ATC classification and DDD assignment. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology. 2004. Available at: http://www.whocc.no/atcddd/indexdatabase/index.php. Accessed 1 february 2005.
Vektis BV. Externe integratie declaratie farmaceutische hulp. 1995 [External integration of declarations for pharmaceutical help]; available at http://www.vektis.nl/index.php. Accessed 1 February 2005.
Koninklijke Nederlandsche Maatschappij tot bevordering der Geneeskunst: Eisen en voorwaarden herregistratie huisartsen. [The Royal Dutch Medical Association: requirements and conditions for reregistration of general practitioners]. Staatscourant 2003;47:18.
Muijrers PEM, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RPTM. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist. Pharm World Sci 2003;25(5):235–41.
Muijrers PEM, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RPTM. Pharmacists in primary care. Determinants of the care-providing function of Dutch community pharmacists in primary care. Pharm World Sci 2004;26(5):256–62.
Olesen F, Vedsted P, Norskov Nielsen J. Change in ranking order of prescribing patterns by age and sex standardization of the practice population. Scand J Prim Health Care 1996;14(3):159–64.
Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003;169(1):17–22.
Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, Downie G, Seymour DG. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30(3):205–11.
Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001;18:63–77.
De Vries CS. Collaboration in healthcare. The tango to drug safety. Dissertation. University of Groningen. The Netherlands;1998
Hamley JH, MacGregor SH, Dunbar JA, Cromarty JA. Integrating clinical pharmacists into the primary health care team: a framework for rational and cost-effective prescribing. Scott Med J 1997;42(1):4–7.
Muijrers PEM, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RPTM. Differences in prescribing between general practitioners. Impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives. Fam Pract (In press, accepted for publication June 29th 2005).
Van Dijk L, Barnhoorn H, De Bakker D. Het Farmacotherapie Overleg in 1999, stand van zaken en effecten op voorschrijven [The Pharmacotherapeutic audit meeting in 1999, current state of affairs and effects on prescribing]. Nivel, Utrecht, The Netherlands; 2001.
Nathan A, Sutters CA. A comparison of community pharmacists’ and general practitioners’ opinions on rational prescribing, formularies and other prescribing related issues. J R Soc Health 1993;113:302–7.
Acknowledgements
We thank the community pharmacists who participated in this study.
Funding: Royal Dutch Association for the Advancement of Pharmacy (KNMP) and CZ health insurance company.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muijrers, P.E.M., Grol, R.P.T.M., Sijbrandij, J. et al. Pharmaceutical care and its relationship to prescribing behaviour of general practitioners. Pharm World Sci 28, 302–308 (2006). https://doi.org/10.1007/s11096-006-9047-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-006-9047-1